阿尔茨海默病、轻度认知障碍与认知健康对照者的脉络膜结构分析
本前瞻性横断面研究纳入67例阿尔茨海默病(AD)患者(112眼)、74例轻度认知障碍(MCI)患者(143眼)和137名认知健康对照者(248眼),采用增强深度成像光学相干断层扫描测量脉络膜参数。多变量分析校正年龄、性别和视力后,AD和MCI患者的脉络膜总面积(TCA)和管腔面积(LA)显著大于对照组,MCI患者脉络膜血管指数(CVI)显著低于对照组,而黄斑中心凹下脉络膜厚度(SFCT)在三组间无显著差异。
要点
- AD和MCI患者TCA、LA较认知健康对照显著增大。
- MCI患者CVI较对照显著降低,AD与对照无显著差异。
- SFCT在三组间多变量分析无显著差异。
核心结论
- TCA、LA和CVI在AD、MCI与认知健康者间可能不同,而SFCT可能无差异。
- TCA、LA和CVI值得在阿尔茨海默病连续谱人群中进一步研究。
研究设计与样本
- 前瞻性横断面研究,纳入67例AD患者(112眼)、74例MCI患者(143眼)和137名对照者(248眼)。
- 排除糖尿病、青光眼或视网膜病变者,使用Zeiss Cirrus HD-5000 AngioPlex获取高清增强深度成像黄斑中心凹扫描。
- 由2名设盲分级者测量SFCT并有第三仲裁者,图像二值化后计算TCA、LA和CVI。
- 采用多变量广义估计方程校正年龄、性别和视力,评估脉络膜参数与AD、MCI或对照的关联。
主要发现
- 校正年龄、性别和视力后,AD患者TCA显著大于对照(ß=2.73;p=.001)。
- 校正后MCI患者TCA显著大于对照(ß=4.38;p<.001)。
- 校正后AD患者LA显著大于对照(ß=1.68;p=.001)。
- 校正后MCI患者LA显著大于对照(ß=2.69;p<.001)。
- 校正后MCI患者CVI显著低于对照(ß=-0.58;p=.002),SFCT在三组间多变量分析无显著差异(p>.05)。
临床怎么用
- 在认知障碍评估中可考虑将TCA、LA和CVI作为候选脉络膜结构标志物进行进一步研究。
- SFCT可能不适用于区分AD、MCI与认知健康者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess choroidal structural parameters in symptomatic Alzheimer disease (AD), mild cognitive impairment (MCI), and cognitively healthy control subjects. DESIGN: Prospective cross-sectional study. METHODS: This study took place in an outpatient neurological disorders clinic. Participants included 67 patients (112 eyes) with AD, 74 patients (143 eyes) with MCI, and 137 (248 eyes) control subjects. Subjects with diabetes, glaucoma, or retinal pathology were excluded. High-definition enhanced depth imaging foveal scans were obtained using Zeiss Cirrus HD-5000 AngioPlex. Subfoveal choroidal thickness (SFCT) was measured by 2 masked graders with a third adjudicator. Total choroidal area (TCA), luminal area (LA), and the choroidal vascularity index (CVI) were calculated after image binarization. Association of choroidal parameters with AD, MCI, or control subjects was assessed using multivariable generalized estimating equations, adjusted for age, sex, and visual acuity. RESULTS: After adjustment for age, sex, and visual acuity, TCA was significantly greater in patients with AD (ß = 2.73; p = .001) and MCI (ß = 4.38; p < .001) compared with control subjects. LA was significantly greater in patients with AD (ß = 1.68; p = .001) and MCI (ß = 2.69; p < .001) compared with control subjects, and CVI was significantly lower in patients with MCI (ß = -0.58; p = .002) compared with control subjects. SFCT was similar among patients with AD and MCI and control subjects on multivariable analysis (p > .05). CONCLUSIONS: TCA, LA, and CVI may differ between patients with AD, MCI, and healthy cognition, whereas SFCT may not differ among these groups. TCA, LA, and CVI deserve further study in subjects on the Alzheimer continuum.
引用
- Robbins CB, Grewal DS, Thompson AC, et al. Choroidal Structural Analysis in Alzheimer Disease, Mild Cognitive Impairment, and Cognitively Healthy Controls. Am J Ophthalmol. 2020. PMID: 33039373. doi:10.1016/j.ajo.2020.09.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。